1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 8th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Double-Blinding and Bias in Medication and Cognitive-Behavioral Therapy Trials for Major Depressive Disorder, 2015, Berger

Discussion in 'Research methodology news and research' started by Woolie, Jun 21, 2021.

  1. Woolie

    Woolie Senior Member

    Messages:
    2,918
    Full reference: Berger, D. (2015). Double-blinding and bias in medication and cognitive-behavioral therapy trials for major depressive disorder. F1000Research, 4.

    Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732552/

    Abstract:
     
    Sean, Michelle, JemPD and 9 others like this.
  2. James Morris-Lent

    James Morris-Lent Senior Member (Voting Rights)

    Messages:
    903
    Location:
    United States
    1. If there isn't good evidence it generally shouldn't be offered under the umbrella of mainstream medicine
    2. If studies are not designed to produce reliable evidence they shouldn't be approved or funded
    3. See 1.
     
    Sean, Michelle, JemPD and 8 others like this.
  3. ME/CFS Skeptic

    ME/CFS Skeptic Senior Member (Voting Rights)

    Messages:
    3,507
    Location:
    Belgium
  4. Woolie

    Woolie Senior Member

    Messages:
    2,918
    Thanks, @Michiel Tack! I just independently re-read your previous thread and came here now to link to it myself!
     
    Peter Trewhitt and MSEsperanza like this.
  5. Snow Leopard

    Snow Leopard Senior Member (Voting Rights)

    Messages:
    3,827
    Location:
    Australia
    My personal preferred term is "randomised comparison trial", rather than "randomised controlled trial"...
     
    Mithriel, Sean, Michelle and 3 others like this.

Share This Page